US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
Optimi Health Corp (OPTI) 銘柄情報

Optimi Health Corp (OPTI)

6.40

0.70

(12.28%)

終了 6月13日 5:00AM

Optimi Health Corp (OPTI) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

6.40

( 12.28% )

買値

6.30

売値

6.48

出来高

8,525

6.20 日の範囲 6.55

0.105 52 週間の範囲 10.25

時価総額

前日終値

5.70

始値

6.39

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 7,399

発行済株式数

5,625,899

配当利回り

PER

-4.35

1 株当たり利益 (EPS)

-1.68

歳入

231.86k

純利益

-5.4M

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The ... Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.optimihealth.ca

本社

Princeton, Canada

設立

2026

Optimi Health Corp is listed in the Healthcare sector of the Canadian Securities Exchange with ticker OPTI. The last closing price for Optimi Health was $5.70. Over the last year, Optimi Health shares have traded in a share price range of $ 0.105 to $ 10.25.

Optimi Health currently has 5,625,899 shares in issue. The market capitalisation of Optimi Health is $36.01 million. Optimi Health has a price to earnings ratio (PE ratio) of -4.35.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.72	-21.1822660099	8.12	8.15	5.7	16262	6.67155969	CS
4	6.075	1869.23076923	0.325	10.25	0.31	28282	4.37443009	CS
12	6.11	2106.89655172	0.29	10.25	0.275	81301	0.79677973	CS
26	6.06	1782.35294118	0.34	10.25	0.25	105462	0.49012695	CS
52	6.24	3900	0.16	10.25	0.105	97156	0.39598823	CS
156	6.165	2623.40425532	0.235	10.25	0.105	72368	0.32457838	CS
260	5.66	764.864864865	0.74	10.25	0.105	76985	0.37155051	CS

OPTI - Frequently Asked Questions (FAQ)

What is the current Optimi Health Corp share price?

The current share price of Optimi Health Corp is $ 6.40

How many Optimi Health Corp shares are in issue?

Optimi Health Corp has 5,625,899 shares in issue

What is the market cap of Optimi Health Corp?

The market capitalisation of Optimi Health Corp is CAD 36.01M

What is the 1 year trading range for Optimi Health Corp share price?

Optimi Health Corp has traded in the range of $ 0.105 to $ 10.25 during the past year

What is the PE ratio of Optimi Health Corp?

The price to earnings ratio of Optimi Health Corp is -4.35

What is the cash to sales ratio of Optimi Health Corp?

The cash to sales ratio of Optimi Health Corp is 176.89

What is the registered address of Optimi Health Corp?

The registered address for Optimi Health Corp is 269 David Brown Way, Princeton, British Columbia, V0X 1W0

What is the Optimi Health Corp website address?

The website address for Optimi Health Corp is www.optimihealth.ca

Which industry sector does Optimi Health Corp operate in?

Optimi Health Corp operates in the Pharmaceuticals sector

Talisman33

Talisman33 7分前

Ask Amazon? More like ask why they don't sell Lunar on Amazon. Did something happen when they tried selling Acute/Defense with them?

SovereignNinja5

SovereignNinja5 14分前

LMAO ok Beer, I know where you get your info. Send my regards. PBM decisions are not what you think.
This is cute.
“Amarin's benefit from the science will come from Europe and ROW, and Guideline upgrades in those regions.”

The OUS Revenue Reality Check
Looking a

iHub News

iHub News 16分前

BofA’s Hartnett Warns Bullish Positioning Remains Entrenched Despite 5% Bond YieldsJune 13, 2026 7:00 AM
IH Market News

iHub News

iHub News 17分前

BofA’s Hartnett Warns Bullish Positioning Remains Entrenched Despite 5% Bond YieldsJune 13, 2026 7:00 AM
IH Market News

Implanting

Implanting 19分前

There's a lot of uncertainty around how this negotiations process with the First Nations even works. Unless you're in the mine start-up business, it's a long, sorted process between the potential miner, government agencies, and the Natives. These community votes may be in most part "window dressing"

brazen22

brazen22 22分前

Doc, the issue is not whether the SAP included bias checks. Of course it did. The issue is whether those checks were sufficient to prove the external control population was comparable enough to support treatment effect.

Bias checks can reduce concern, but they do not create randomizat

FooBarAndGrill

FooBarAndGrill 22分前

Yes. Quite entertaining.
https://www.linkedin.com/feed/update/urn:li:activity:7470142453950447616/

ITYS

Yes, yes ...we all know what the bid and ask are.
You’re explaining mechanics like that’s the issue here, when the real problem is you’re trying to apply big-float logic to a 9.7M float. That’s why your whole “we need volume every day” argument falls apart.

You keep talking lik

nicehit

nicehit 27分前

Umm, they say Quantum was 20 years away. It's here today. Fusion is coming, and both (Fusion/Nuclear) will co-exist!

yielddude

yielddude 31分前

Congrats SteveSchiets! And to Nsom as well. And thanks again to Sskillz1 for running these contests.

gerry57

gerry57 33分前

I recognize your name from another board . Let’s hope this ceo is far more competent and trustworthy, this moa while different tries to accomplish the same sort of endgame, a neuron closer to homeostasis .

US Market News

US Market News 47分前

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myelomaJune 13, 2026 6:33 AM
PR Newswire (US)

band aid

band aid 47分前

She said after the New Year we would learn more. Got to cut her some slack LOL it's only mid June. Maybe she meant Christmas in July. Anyway you look at it it's a new start up company that takes a lil time to raise capital to buy relish for the hotdog stand.

Investor082

Investor082 52分前

Gary, Eden won’t be certified for commercial production until 2028 at the earliest. That too is highly uncertain and unlikely given NWBO’s history. In fact, its more likely they abandon the project or find some excuse to stall in 2027 than a commercial certification of Eden in 2028.

W

TRAPPER JIM

TRAPPER JIM 56分前

I got all the ceilings downstairs painted except for the kitchen and the bathroom last night. So the only ceilings I have left to paint now are the kitchen, bathroom, one closet and the laundry room. And I’m not sure about the garage ceiling. I need to look at it today. Just thought about that one.

Investor082

Investor082 58分前

“No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA approval for years or until they complete additional trials.”

- I agree with that. This is why no institutiona

US Market News

US Market News 1時間前

Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United StatesJune 13, 2026 6:22 AM
Business Wire Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together refer

StockItOut

StockItOut 1時間前

Now how do you know that?

“BOXABL has actually been in contact with XERI.”

.

Investor082

Investor082 1時間前

LOL, no excuses when Flaskworks is not certified for commercial production this year and then again next year, OK?

Anything else is just fluff at this point. It will again prove they are desperate to PR anything and that more importantly UK decision is many months away.

cottonisking

cottonisking 1時間前

Lehman Brothers and Reality (Class 10B payday ?): 14 sites Reality is the totality of all things that exist, independent of whether we are aware of them, believe in them, or understand them. While that definition sounds simple, how reality actually operates depends entirely on the lens—scientific, p

Ranb2khz

Ranb2khz 1時間前

Pentagon releases third batch of UFO files, including civilian videos

~ by www.christianpost.com/by/cp-staff CP Staff , June 13, 2026
____________

The Pentagon released its third batch of files related to unidentified anomalous phenomena (UAPs) or UFOs on Frida

SCAMBUSTERKING

SCAMBUSTERKING 1時間前

You are the only shareholder, this board exists solely to ensure no more shareholders are created.

US Market News

US Market News 2時間前

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free SurvivalJune 13, 2026 6:00 AM
Business Wire - f

Ranb2khz

Ranb2khz 2時間前

In Other News: Google Security Layoffs, AudiA6 Takedown, $400 Million Coupang Fine

~ Other noteworthy stories that might have slipped under the radar: ICS device exposure remains flat as attack surface widens, Microsoft issues incident response playbook for AI, IBM and AT&T accused of

Give Me Power (EM)

Bmo Selecttrust Income P...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。